Arrowhead Pharmaceuticals
ARWR
#2176
Rank
$8.49 B
Marketcap
$61.44
Share price
-4.98%
Change (1 day)
160.23%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of June 2025 : $0.35 Billion USD

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is $0.35 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-09-30$0.51 B343.3%
2023-09-30$0.11 B41.18%
2022-09-30$81.57 M219.34%
2021-09-30$25.54 M20.85%
2020-09-30$21.13 M
2019-09-30N/A-100%
2018-09-30$2.32 M-8.23%
2017-09-30$2.53 M-7.12%
2016-09-30$2.72 M259.7%
2015-09-30$0.75 M-25.82%
2014-09-30$1.02 M-55.63%
2013-09-30$2.3 M-5.44%
2012-09-30$2.43 M301.57%
2011-09-30$0.6 M21.36%
2010-09-30$0.5 M-59.23%
2009-09-30$1.22 M-20.2%
2008-09-30$1.53 M
2002-09-30$0.63 M13.33%
2001-09-30$0.55 M-0.71%
2000-09-30$0.56 M-0.35%
1999-09-30$0.56 M-47.19%
1998-09-30$1.06 M4.49%
1997-09-30$1.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alnylam Pharmaceuticals
ALNY
$1.30 B 270.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.45 B 27.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
$10.02 M-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$45.79 B 12,871.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
$0.73 B 107.91%๐Ÿ‡บ๐Ÿ‡ธ USA